For the twelve months ended Sep 30, 2026, Intuitive Surgical Inc. reported $11.58B of revenue and $2.96B of net income.
ISRG revenue was $3.05B in fiscal Q3 2026 (ended Sep 30, 2026), up 21.7% from a year earlier and up 5.4% from the prior quarter. For the full fiscal 2025 it was $10.06B, up 20.5% from fiscal 2024. Compound annual growth was +18.2% over 5 years and +15.5% over 10 years. It rose in 9 of the last 10 fiscal years. Fiscal 2025 is the highest of the 15 fiscal years on file.
ISRG net income was $522.80M in fiscal Q3 2026 (ended Sep 30, 2026), down 25.8% from a year earlier and down 36.1% from the prior quarter. For the full fiscal 2025 it was $2.86B, up 23.0% from fiscal 2024. Compound annual growth was +21.9% over 5 years and +17.1% over 10 years. It rose in 7 of the last 10 fiscal years. Fiscal 2025 is the highest of the 15 fiscal years on file.
ISRG diluted EPS was $1.49 in fiscal Q3 2026 (ended Sep 30, 2026), down 23.6% from a year earlier and down 34.9% from the prior quarter. For the full fiscal 2025 it was $7.87, up 22.6% from fiscal 2024. Compound annual growth was +21.8% over 5 years and +16.4% over 10 years.
ISRG free cash flow was $1.11B in fiscal Q3 2026 (ended Sep 30, 2026), up 51.0% from a year earlier and up 17.1% from the prior quarter. For the full fiscal 2025 it was $2.49B, up 91.0% from fiscal 2024. Compound annual growth was +16.9% over 5 years and +13.1% over 10 years. It rose in 6 of the last 10 fiscal years. Fiscal 2025 is the highest of the 15 fiscal years on file.
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10.06B | $8.35B | $7.12B | $6.22B | $5.71B | $4.36B | $4.48B | $3.72B | $3.14B | $2.71B |
| Cost of revenue | $3.42B | $2.72B | $2.39B | $2.03B | $1.75B | $1.50B | $1.37B | $1.12B | $936.20M | $813.60M |
| Gross profit | $6.64B | $5.63B | $4.73B | $4.20B | $3.96B | $2.86B | $3.11B | $2.60B | $2.20B | $1.89B |
| Research and development | $1.31B | $1.15B | $998.80M | $879.00M | $671.00M | $595.10M | $557.30M | $418.10M | $328.60M | $239.60M |
| Selling, general and admin | $2.38B | $2.14B | $1.96B | $1.74B | $1.47B | $1.22B | $1.18B | $986.60M | $810.50M | $703.60M |
| Operating income | $2.95B | $2.35B | $1.77B | $1.58B | $1.82B | $1.05B | $1.37B | $1.20B | $1.06B | $949.70M |
| Pre-tax income | $3.31B | $2.67B | $1.96B | $1.61B | $1.89B | $1.21B | $1.50B | $1.28B | $1.10B | $985.30M |
| Income tax | $434.80M | $336.30M | $141.60M | $262.40M | $162.20M | $140.20M | $120.40M | $154.50M | $433.90M | $247.00M |
| Net income | $2.86B | $2.32B | $1.80B | $1.32B | $1.70B | $1.06B | $1.38B | $1.13B | $670.90M | $738.30M |
| EPS, basic | $8.00 | $6.54 | $5.12 | $3.72 | $4.79 | $3.02 | $3.98 | $3.31 | $2.00 | $2.14 |
| EPS, diluted | $7.87 | $6.42 | $5.03 | $3.65 | $4.66 | $2.94 | $3.85 | $3.16 | $1.92 | $2.09 |
| Diluted shares | 362.7M | 362.0M | 357.4M | 362.0M | 365.8M | 361.0M | 358.4M | 356.4M | 348.9M | 353.7M |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $3.37B | $2.06B | $2.77B | $1.60B | $1.31B | $1.64B | $1.18B | $909.40M | $663.20M | $1.05B |
| Short-term investments | $2.57B | $1.99B | $2.47B | $2.54B | $2.91B | $3.49B | $2.05B | $2.21B | $1.31B | $1.52B |
| Receivables | $1.53B | $1.23B | $1.13B | $942.10M | $782.70M | $645.50M | $645.20M | $682.30M | $507.90M | $430.20M |
| Inventory | $1.84B | $1.49B | $1.22B | $893.20M | $587.10M | $601.50M | $595.50M | $409.00M | $241.20M | $182.30M |
| Current assets | $9.78B | $7.11B | $7.89B | $6.25B | $5.84B | $6.63B | $4.66B | $4.33B | $2.81B | $3.25B |
| Goodwill | $370.30M | $347.50M | $348.70M | $348.50M | $343.60M | $336.70M | $307.20M | $240.60M | $201.10M | $201.10M |
| Total assets | $20.46B | $18.74B | $15.44B | $12.97B | $13.55B | $11.17B | $9.73B | $7.85B | $5.78B | $6.49B |
| Current liabilities | $2.01B | $1.75B | $1.66B | $1.42B | $1.15B | $965.20M | $1.03B | $820.60M | $662.80M | $596.50M |
| Total liabilities | $2.52B | $2.21B | $2.04B | $1.86B | $1.60B | $1.41B | $1.45B | $1.16B | $996.40M | $709.10M |
| Shareholders' equity | $17.82B | $16.53B | $13.40B | $11.11B | $11.95B | $9.76B | $8.28B | $6.69B | $4.78B | $5.82B |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $3.03B | $2.42B | $1.81B | $1.49B | $2.09B | $1.48B | $1.60B | $1.17B | $1.14B | $1.09B |
| Capital expenditures | $539.80M | $1.11B | $1.06B | $532.40M | $339.50M | $341.50M | $425.60M | $187.40M | $190.70M | $53.90M |
| Free cash flow | $2.49B | $1.30B | $749.60M | $958.40M | $1.75B | $1.14B | $1.17B | $982.20M | $953.20M | $1.03B |
| Investing cash flow | $665.80M | -$3.27B | -$360.10M | $1.37B | -$2.46B | -$940.60M | -$1.15B | -$1.05B | $378.70M | -$1.28B |
| Financing cash flow | -$2.36B | $150.90M | -$287.60M | -$2.57B | $43.00M | -$85.70M | -$168.40M | $126.30M | -$1.91B | $514.40M |
| Share repurchases | $2.30B | $0 | $416.30M | $2.61B | $0 | $134.30M | $269.50M | $0 | $2.27B | $42.50M |
| Stock-based compensation | $788.20M | $676.80M | $592.80M | $513.20M | $449.20M | $395.40M | $335.80M | $261.20M | $209.10M | $177.60M |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | 20.5% | 17.2% | 14.5% | 9.0% | 31.0% | -2.7% | 20.3% | 18.7% | 16.0% | 13.5% |
| Net income growth, YoY | 23.0% | 29.2% | 36.0% | -22.4% | 60.7% | -23.1% | 22.3% | 68.1% | -9.1% | 25.4% |
| EPS growth, YoY | 22.6% | 27.6% | 37.8% | -21.7% | 58.5% | -23.6% | 21.7% | 64.5% | -7.8% | 20.8% |
| Gross margin | 66.0% | 67.5% | 66.4% | 67.4% | 69.3% | 65.6% | 69.4% | 69.9% | 70.2% | 69.9% |
| Operating margin | 29.3% | 28.1% | 24.8% | 25.3% | 31.9% | 24.1% | 30.7% | 32.2% | 33.9% | 35.1% |
| Net margin | 28.4% | 27.8% | 25.2% | 21.3% | 29.9% | 24.3% | 30.8% | 30.3% | 21.4% | 27.3% |
| Free cash flow margin | 24.7% | 15.6% | 10.5% | 15.4% | 30.6% | 26.2% | 26.2% | 26.4% | 30.4% | 38.2% |
| Return on equity | 16.0% | 14.1% | 13.4% | 11.9% | 14.3% | 10.9% | 16.6% | 16.9% | 14.0% | 12.7% |
| Return on assets | 14.0% | 12.4% | 11.6% | 10.2% | 12.6% | 9.5% | 14.2% | 14.4% | 11.6% | 11.4% |
| Current ratio | 4.87 | 4.07 | 4.76 | 4.40 | 5.08 | 6.86 | 4.53 | 5.28 | 4.24 | 5.45 |
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.05B | $2.89B | $2.77B | $2.87B | $2.51B | $2.44B | $2.25B | $2.41B | $2.04B | $2.01B | $1.89B | $1.93B |
| Cost of revenue | $964.40M | $931.90M | $940.30M | $961.90M | $842.70M | $822.10M | $795.70M | $771.30M | $664.20M | $637.20M | $645.20M | $650.90M |
| Gross profit | $2.08B | $1.96B | $1.83B | $1.90B | $1.66B | $1.62B | $1.46B | $1.64B | $1.37B | $1.37B | $1.25B | $1.28B |
| Research and development | $408.30M | $370.60M | $361.90M | $352.90M | $329.40M | $313.30M | $316.20M | $294.70M | $286.00M | $280.10M | $284.50M | $260.10M |
| Selling, general and admin | $633.40M | $617.90M | $613.30M | $687.10M | $573.30M | $561.20M | $563.40M | $612.60M | $510.60M | $525.30M | $491.50M | $567.10M |
| Operating income | $592.60M | $971.90M | $855.30M | $864.30M | $759.70M | $743.40M | $578.10M | $734.90M | $577.30M | $567.30M | $469.40M | $450.20M |
| Pre-tax income | $668.40M | $1.05B | $940.40M | $955.60M | $855.20M | $832.10M | $668.50M | $809.80M | $671.00M | $654.50M | $538.50M | $515.90M |
| Income tax | $144.00M | $231.40M | $114.40M | $156.10M | $146.00M | $167.90M | -$35.20M | $121.80M | $100.40M | $123.00M | -$8.90M | -$94.80M |
| Net income | $522.80M | $818.10M | $821.50M | $794.80M | $704.40M | $658.40M | $698.40M | $685.70M | $565.10M | $526.90M | $544.90M | $606.20M |
| EPS, basic | $1.50 | $2.31 | $2.31 | $2.23 | $1.98 | $1.84 | $1.95 | $1.93 | $1.59 | $1.48 | $1.54 | $1.73 |
| EPS, diluted | $1.49 | $2.29 | $2.28 | $2.19 | $1.95 | $1.81 | $1.92 | $1.89 | $1.56 | $1.46 | $1.51 | $1.69 |
| Diluted shares | 351.6M | 357.3M | 359.8M | - | 361.8M | 364.1M | 364.6M | - | 362.7M | 361.0M | 360.5M | - |
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $2.98B | $2.76B | $2.01B | $3.37B | $2.85B | $3.45B | $2.62B | $2.06B | $2.45B | $3.07B | $2.87B | $2.77B |
| Short-term investments | $1.06B | $2.46B | $2.51B | $2.57B | $2.10B | $1.92B | $1.94B | $1.99B | $1.82B | $1.72B | $1.96B | $2.47B |
| Receivables | $1.72B | $1.67B | $1.60B | $1.53B | $1.26B | $1.27B | $1.22B | $1.23B | $1.15B | $1.11B | $1.13B | $1.13B |
| Inventory | $2.13B | $2.03B | $1.95B | $1.84B | $1.78B | $1.67B | $1.55B | $1.49B | $1.48B | $1.38B | $1.30B | $1.22B |
| Current assets | $8.43B | $9.54B | $8.81B | $9.78B | $8.53B | $8.75B | $7.66B | $7.11B | $7.22B | $7.65B | $7.63B | $7.89B |
| Goodwill | $557.80M | $580.60M | $613.20M | $370.30M | $348.10M | $348.70M | $347.50M | $347.50M | $348.30M | $348.00M | $348.20M | $348.70M |
| Total assets | $19.35B | $20.88B | $20.11B | $20.46B | $19.35B | $20.16B | $19.22B | $18.74B | $17.74B | $16.65B | $15.83B | $15.44B |
| Current liabilities | $2.53B | $1.92B | $1.91B | $2.01B | $1.80B | $1.69B | $1.54B | $1.75B | $1.68B | $1.49B | $1.38B | $1.66B |
| Total liabilities | $3.23B | $2.58B | $2.51B | $2.52B | $2.31B | $2.21B | $2.01B | $2.21B | $2.07B | $1.85B | $1.78B | $2.04B |
| Shareholders' equity | $15.99B | $18.30B | $17.60B | $17.82B | $17.04B | $17.95B | $17.21B | $16.53B | $15.68B | $14.80B | $14.05B | $13.40B |
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.22B | $1.06B | $911.90M | $892.50M | $841.00M | $715.40M | $581.60M | $822.60M | $706.50M | $620.50M | $265.40M | $228.30M |
| Capital expenditures | $113.10M | $112.60M | $103.30M | $162.50M | $105.40M | $155.30M | $116.60M | $312.00M | $247.90M | $309.40M | $241.90M | $435.50M |
| Free cash flow | $1.11B | $948.40M | $808.60M | $730.00M | $735.60M | $560.10M | $465.00M | $510.60M | $458.60M | $311.10M | $23.50M | -$207.20M |
| Investing cash flow | $1.90B | -$26.60M | -$914.50M | -$209.40M | $401.00M | $260.70M | $213.50M | -$1.26B | -$1.41B | -$467.10M | -$128.50M | -$1.04B |
| Financing cash flow | -$2.89B | -$287.90M | -$1.35B | -$137.50M | -$1.84B | -$147.80M | -$235.80M | $49.40M | $98.20M | $50.00M | -$46.70M | -$31.50M |
| Dividends paid | - | - | - | - | $0 | - | - | - | $0 | - | - | - |
| Share repurchases | $2.98B | $320.30M | $1.12B | $201.00M | $1.91B | $181.00M | $0 | $0 | $0 | $0 | $0 | $66.30M |
| Stock-based compensation | $212.60M | $209.90M | $209.50M | $203.30M | $203.50M | $196.20M | $185.20M | $177.00M | $172.90M | $173.60M | $153.30M | $150.40M |
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | 21.7% | 18.5% | 23.0% | 18.8% | 22.9% | 21.4% | 19.2% | 25.2% | 16.9% | 14.5% | 11.5% | 16.5% |
| Net income growth, YoY | -25.8% | 24.3% | 17.6% | 15.9% | 24.7% | 25.0% | 28.2% | 13.1% | 35.9% | 25.2% | 53.4% | 86.6% |
| EPS growth, YoY | -23.6% | 26.5% | 18.8% | 15.9% | 25.0% | 24.0% | 27.2% | 11.8% | 34.5% | 23.7% | 51.0% | 87.8% |
| Gross margin | 68.4% | 67.8% | 66.1% | 66.4% | 66.4% | 66.3% | 64.7% | 68.0% | 67.4% | 68.3% | 65.9% | 66.2% |
| Operating margin | 19.4% | 33.6% | 30.9% | 30.2% | 30.3% | 30.5% | 25.7% | 30.4% | 28.3% | 28.2% | 24.8% | 23.3% |
| Net margin | 17.1% | 28.3% | 29.6% | 27.7% | 28.1% | 27.0% | 31.0% | 28.4% | 27.7% | 26.2% | 28.8% | 31.4% |
| Free cash flow margin | 36.4% | 32.8% | 29.2% | 25.5% | 29.4% | 23.0% | 20.6% | 21.2% | 22.5% | 15.5% | 1.2% | -10.7% |
| Current ratio | 3.33 | 4.96 | 4.61 | 4.87 | 4.73 | 5.17 | 4.98 | 4.07 | 4.30 | 5.15 | 5.55 | 4.76 |
Source: XBRL data Intuitive Surgical Inc. files with the SEC, latest filing dated Oct 21, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.
Per-share figures and share counts are restated for stock splits the filings show: 3-for-1, first reported Oct 20, 2017; 3-for-1, first reported Oct 20, 2021.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| ISRG | $11.58B | +20.5% | $2.96B | 25.5% | $156.96B |
| EW | $6.67B | +13.4% | $1.02B | 15.3% | $58.73B |
| STE | $6.17B | +8.1% | $826.90M | 13.4% | $24.60B |
| ZBH | $8.57B | +7.0% | $767.30M | 9.0% | $19.98B |
| MAS | $7.67B | +0.9% | $926.00M | 12.1% | $15.85B |
| SNN | $6.16B | +6.1% | $625.00M | 10.1% | $13.04B |
| ALGN | $4.16B | +4.4% | $491.87M | 11.8% | $11.70B |
| AIT | $5.06B | +8.5% | $424.12M | 8.4% | $10.35B |
| POOL | $5.45B | +2.9% | $395.95M | 7.3% | $7.56B |